613 related articles for article (PubMed ID: 23770121)
1. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
3. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
Langen RC; Gosker HR; Remels AH; Schols AM
Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
6. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
7. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia.
Martins T; Vitorino R; Moreira-Gonçalves D; Amado F; Duarte JA; Ferreira R
Clin Biochem; 2014 Jan; 47(1-2):8-15. PubMed ID: 24184665
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways perturbing muscle mass.
Glass DJ
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
[TBL] [Abstract][Full Text] [Related]
9. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
12. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
13. Control of food intake and muscle wasting in cachexia.
Amitani M; Asakawa A; Amitani H; Inui A
Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
[TBL] [Abstract][Full Text] [Related]
14. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD.
Vogiatzis I; Simoes DC; Stratakos G; Kourepini E; Terzis G; Manta P; Athanasopoulos D; Roussos C; Wagner PD; Zakynthinos S
Eur Respir J; 2010 Aug; 36(2):301-10. PubMed ID: 20110400
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
16. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
18. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
19. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
20. Effects of 3 days unloading on molecular regulators of muscle size in humans.
Gustafsson T; Osterlund T; Flanagan JN; von Waldén F; Trappe TA; Linnehan RM; Tesch PA
J Appl Physiol (1985); 2010 Sep; 109(3):721-7. PubMed ID: 20538844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]